新種の血小板膜グリコプロテインVI二形態化は,心筋梗塞の危険因子です
S A Croft1, N J Samani, M D Teare
1Division of Genomic Medicine, University of Sheffield, Sheffield, UK.
Circulation
|September 26, 2001
まとめ
グリコプロテインVI (GP VI) の遺伝的変異は,心筋梗塞 (MI) リスクに影響します. GP VI 13254CC遺伝子型は,特に高齢者および他の遺伝因子と相互作用するときに,MIのリスクの増加に関連しています.
科学分野:
- 心血管遺伝学 心血管遺伝学
- 血小板生物学 血小板生物学について
- 分子医学は分子医学である.
背景:
- グリコタンパク質VI (GP VI) は,血小板の活性化と集積に不可欠です.
- GP VI遺伝子の多形変異は,心筋梗塞 (MI) リスクにおける潜在的な役割について調査されています.
研究 の 目的:
- GP VIロカスにおける遺伝的変異が心筋梗塞 (MI) のリスクを高めるかどうかを判断する.
主な方法:
- ポリメラーゼ連鎖反応と適合感のゲル電泳を用いたGP VI遺伝子のコーディング領域と非コーディング領域の分析.
- アミノ酸置換を予測する5つを含む10の二形態の識別.
- ロジスティック回帰分析を用いた患者および対照群におけるMIリスクに対するT13254C二形態の寄与の評価.
主要な成果:
- 5つの二元性はアミノ酸の置換を予測し,2つのコアハプロタイプが特定されました.
- GP VIのT13254C二形態 (Ser219Pro) は,MIのアレル確率比 (OR) が1.16であることを示しました.
- 13254CC遺伝子型は,女性,非喫煙者,高齢 (>60歳) の心筋梗塞患者,およびベータ-フィブリノゲン-148Tアレルを持つ患者でより一般的であった.
- ロジスティック回帰では,GP VI遺伝子型と年齢 (P=0.005) とβ-フィブリノゲン遺伝子型 (P=0.035) の間に有意な相互作用が見つかりました.
結論:
- GP VI 13254CC遺伝子型は,心筋梗塞 (MI) のリスクの増加と関連しています.
- このリスクは,高齢者において特に高くなります.
- GP VI 13254C アレルと他のリスクアレルとの相互作用は,さらにMRIリスクを高めることがあります.
関連する概念動画
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

